These findings led us to speculate that, in a subset of immunosuppressed breast tumors, upregulated TGF-β signaling may coopt OTUD4 to hyperactively deubiquitylate CD73, thereby enhancing its stability and membrane abundance, immune evasion, and maintaining a protumor microenvironment. The gene discussed is TGFB1; the disease is breast neoplasm.